Axsome Therapeutics, Inc. (AXSM) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.68 | +38.6% |
| 2024 | $-5.99 | -13.7% |
| 2023 | $-5.27 | -14.6% |
| 2022 | $-4.60 | -32.6% |
| 2021 | $-3.47 | -25.3% |
| 2020 | $-2.77 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.68 | +38.6% |
| 2024 | $-5.99 | -13.7% |
| 2023 | $-5.27 | -14.6% |
| 2022 | $-4.60 | -32.6% |
| 2021 | $-3.47 | -25.3% |
| 2020 | $-2.77 | — |